Search Results
Results found for "Murat Tunaboylu"
- Murat Tunaboylu & Ben Holland | Dr. GPCR Ecosystem
<< Back to podcast list Strategic Partner(s) Murat Tunaboylu & Ben Holland About Murat Tunaboylu "Murat Tunaboylu, Antiverse's CEO, has a software engineering and bioinformatics background. After switching to biotech, Murat has built cell imaging software and lab robots to accelerate cancer Murat Tunaboylu on the web Antiverse DSV Future of Drug Discovery Podcast Twist Bioscience LinkedIn Twitter
- Yamina's Corner | Dr. GPCR Ecosystem
Murat Tunaboylu, CEO Antiverse Before engaging Yamina, our team faced hurdles navigating complex early
- YC-BioTech | Dr. GPCR Ecosystem
. - Murat Tunabolyu, CEO Antiverse ! Widget Didn’t Load Check your internet and refresh this page.
- Dr. GPCR Community Presentation | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Zozaya "My doctoral research was focused on investigating the cellular effects of missense lung cancer-mutations
- GPCR CRO Bank | Dr. GPCR Ecosystem
. 🌐 Join a Curated Ecosystem Become part of a collaborative, curated ecosystem—not just another name
- Nicole Perry-Hauser | Dr. GPCR Ecosystem
Mutations in aGPCRs have been linked to various neuropsychiatric phenotypes, and my work will provide
- Media Partner Packages | Dr. GPCR Ecosystem
. 🌐 Join a Curated Ecosystem Become part of a collaborative, curated ecosystem—not just another name
- Fluorescent Probes for GLP-1R and GIPR Imaging: From Cell Assays to In Vivo Systems | Dr. GPCR Ecosystem
It provides curated industry intelligence, expert-led masterclasses, and structured engagement opportunities Curated intelligence on GPCR drug discovery trends and developments Expert-led webinars and masterclasses
- Atypical Structure and Function of Typical Chemokine Receptors
This is a rare neurodevelopmental disorder caused by de novo mutations in the GRIN genes that encode
- GPCR University Group Package | Dr. GPCR Ecosystem
Access expert-led courses, 200+ talks, community tools, and curated insights designed to keep your team
- Inhibition of Relaxin Autocrine Signaling Confers Therapeutic Vulnerability in Ovarian Cancer
The adapter protein 3BP2 is mutated in Cherubism.
- About Dr. GPCR Ecosystem | Uniting the GPCR Community to Advance Drug Discovery
Educate — Courses, talks, and curated content that turn expertise into execution.
- Who We Are | Dr. GPCR Ecosystem
GPCR to: Curate relevant data—not overwhelm you with it Connect researchers with CROs, peers, and biotech content block is built to help you make a decision or move forward. ✔ GPCR-specific content ✔ Expert curation
- Dr. Randy Hall | Dr. GPCR Ecosystem
Randy’s lab has a special interest in studying disease-associated mutations to human GPCRs that perturb
- University | Dr. GPCR Ecosystem
Stay ahead with complete GPCR coverage News, papers, jobs, and industry insights — all curated for scientists At Dr.GPCR University, you’ll find: • Courses: Dive deep into curated educational content designed by
- Student Flash Presentations | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Abstract "Li-Fraumeni syndrome (LFS) is a rare cancer predisposition syndrome caused by a germline mutation Glioblastoma (GBM) is the most prevalent central nervous system tumor in LFS, with TP53 mutations detected that ADGRB3 functions as a tumor suppressor in the brain, and its silencing, in the context of p53 mutation flexibility of GAIN flaps affects aGPCR function under native conditions, we strategically inserted specific mutations
- Re-cap of Endocrine Metabolic GPCR 2024 with the Organizers | Dr. GPCR Ecosystem
2012 from the University of Oxford, where her research focused on the cellular mechanisms by which mutations
- Posters | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
cancers, BAI1-3 expression can be lost through epigenetic silencing, copy number loss or truncating mutations WNT pathway activation in WNT-MB is driven by mutations of the CTNNB1 gene, activating ß-catenin-dependent GAIN-targeted antibodies, and cancer-associated mutations at the GAIN-7TM interface, alter holoreceptor
- Dr. Michael Feigin | Dr. GPCR Ecosystem
analysis of cancer drivers by co-developing GECCO, an algorithm for the identification of noncoding mutations He highlighted their interest in non-coding mutations in promoters and the 3'UTR region important for
- Foundry for GPCR Organizations | Dr. GPCR Ecosystem
Leverage a trusted GPCR partner network: access curated CROs, consultants, and collaborators with proven
- Dr. GPCR Team | Dr. GPCR Ecosystem
During that time, I investigated the effect of lung cancer-related mutations in the GAIN domain of the
- Univeristy Lecturers Details | Dr. GPCR Ecosystem
. 🧱 Step 2: Plan Your Course Structure Decide how your course will flow — number of modules, duration
- Session II | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Zozaya "My doctoral research was focused on investigating the cellular effects of missense lung cancer-mutations
- Session V | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Mutational experiments on residues of interest showed that restoring the Phe-His interaction in the uncleaving
- Smells Like GPCR Spirit: Cracking Olfactory Codes with Alessandro Nicoli | Dr. GPCR Ecosystem
.” – Alessandro Nicoli He emphasized that MD allows researchers to observe allosteric changes , mutation
- GPCR Courses | Dr. GPCR Ecosystem
Explore a curated list of GPCR Courses to enhance your knowledge and career.
- Pod-Be Our Guest - Public | Dr. GPCR Ecosystem
The duration of the podcast recording may vary depending on the episode's topic and the flow of the conversation
- Terms and Conditions | Dr. GPCR Ecosystem
Services; a suspension or other action taken with respect to Customer’s account or breach of the ATS; the duration










